HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
Quote:
Login Free Membership
Search:

Analyst Blog  

PX Signs CO2 Contract with Osage

Share
By: Zacks Equity Research
July 14, 2010 |Comments: 0
Recommended this article (1)
PX | APD | ARG | BOY.L

Praxair Inc. (PX) has signed a contract to purchase carbon dioxide (CO2) from Osage Bio Products, an affiliate of Osage Bio Energy for 15 years. The carbon dioxide will be produced by fermenting barley to convert it to ethanol at Osage’s Appomattox Bio Energy plant at Hopewell, Virginia. The plant is expected to start production in August 2010.
 
The carbon dioxide will be purified and liquefied at Praxair’s new plant, expected to be operational by the fourth quarter of 2011, and will produce up to 450 tons per day. The gas will be used primarily for food freezing and processing and beverage applications.
 
Praxair is a premier industrial gas supplier in the Americas and internationally. The company’s intense focus on expanding its reach within its operating regions and adding new customers has accelerated its profit growth, which should continue in the future. Furthermore, Praxair stands well positioned to benefit from the favorable economic environment, given its broad end-market exposure to food and beverage, steel, glass and chemicals.
 
However, Praxair’s large international presence increases risks related to fluctuations in foreign currencies and geopolitical uncertainties. Also, volatility in energy prices increases the risk of energy supply in adverse economic conditions.
 
Praxair expects diluted earnings per share to be in the range of $1.10 to $1.15 for the second quarter of 2010 and within $4.42–$4.57 for full-year 2010. Total revenue for full-year 2010 is expected to be approximately $10.0 billion.
 
Praxair faces stiff competition from Air Products and Chemicals Inc. (APD); Airgas Inc. (ARG); Linde AG (LNAGF.PK); Chromalloy Gas Turbine Corporation and Bodycote (BOY.L). We are currently maintaining a Neutral recommendation on Praxair, which is supported by Zacks # 3(Hold) Rank.

Read the full analyst report on PX

Read the full analyst report on APD

Read the full analyst report on ARG

Read the full analyst report on BOY.L

 
Add a Comment

Please login or register to post a comment



Email

Print

Share

Rate Pos

Rate Neg

Comment

More Zacks Resources

Market Summary Feb 10, 2012 16:37 pm ET
DJIA 12801.23  -89.23 -0.69%
NASD 2903.88  -23.35 -0.80%
S&P 500 1342.64  -9.31 -0.69%
Partner Center